Literature DB >> 10848804

Mesenchymal progenitor cells in human umbilical cord blood.

A Erices1, P Conget, J J Minguell.   

Abstract

Haemopoiesis is sustained by two main cellular components, the haematopoietic cells (HSCs) and the mesenchymal progenitor cells (MPCs). MPCs are multipotent and are the precursors for marrow stroma, bone, cartilage, muscle and connective tissues. Although the presence of HSCs in umbilical cord blood (UCB) is well known, that of MPCs has been not fully evaluated. In this study, we examined the ability of UCB harvests to generate in culture cells with characteristics of MPCs. Results showed that UCB-derived mononuclear cells, when set in culture, gave rise to adherent cells, which exhibited either an osteoclast- or a mesenchymal-like phenotype. Cells with the osteoclast phenotype were multinucleated, expressed TRAP activity and antigens CD45 and CD51/CD61. In turn, cells with the mesenchymal phenotype displayed a fibroblast-like morphology and expressed several MPC-related antigens (SH2, SH3, SH4, ASMA, MAB 1470, CD13, CD29 and CD49e). Our results suggest that preterm, as compared with term, cord blood is richer in mesenchymal progenitors, similar to haematopoietic progenitors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848804     DOI: 10.1046/j.1365-2141.2000.01986.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  404 in total

1.  Host origin of marrow mesenchymal stem cells following allogeneic cord-blood stem-cell transplantation.

Authors:  S Hongeng; S Petvises; B Rerkamnuaychoke; S Worapongpaiboon; P Tardtong; S Apibal; A Ungkanont
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

Review 2.  Mesenchymal stem cells. A potential source for skeletal repair.

Authors:  W E Fibbe
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 3.  Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.

Authors:  Jennifer M Ryan; Allison R Pettit; Pascale V Guillot; Jerry K Y Chan; Nicholas M Fisk
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

Review 4.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

5.  Chondrogenesis from umbilical cord blood cells stimulated with BMP-2 and BMP-6.

Authors:  Cristiane Sampaio de Mara; A S S Duarte; A R Sartori-Cintra; A C M Luzo; S T O Saad; I B Coimbra
Journal:  Rheumatol Int       Date:  2012-01-12       Impact factor: 2.631

6.  Expression pattern of embryonic stem cell markers in DFAT cells and ADSCs.

Authors:  Qian Gao; Lili Zhao; Ziyi Song; Gongshe Yang
Journal:  Mol Biol Rep       Date:  2012-01-12       Impact factor: 2.316

7.  Expression of transcriptional factor genes (Oct-4, Nanog, and Sox-2) and embryonic stem cell-like characters in placental membrane of Buffalo (Bubalus bubalis).

Authors:  Kapil Dev; Shiv Kumar Giri; Anil Kumar; Anita Yadav; Birbal Singh; Sanjeev Kumar Gautam
Journal:  J Membr Biol       Date:  2012-04-22       Impact factor: 1.843

8.  Mesenchymal stem cells from umbilical cord blood: parameters for isolation, characterization and adipogenic differentiation.

Authors:  Tatiana Taís Sibov; P Severino; L C Marti; L F Pavon; D M Oliveira; P R Tobo; A H Campos; A T Paes; E Amaro; L F Gamarra; C A Moreira-Filho
Journal:  Cytotechnology       Date:  2012-02-12       Impact factor: 2.058

Review 9.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 10.  Stem cells: novel players in the treatment of erectile dysfunction.

Authors:  Haiyang Zhang; Maarten Albersen; Xunbo Jin; Guiting Lin
Journal:  Asian J Androl       Date:  2011-10-17       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.